US House committee probes tobacco center’s ‘failure to regulate effectively’

The US House of Representatives Committee on Oversight and Accountability has launched an investigation into the Food and Drug Administration (FDA)’s Center for Tobacco Products (CTP) for alleged failure to effectively regulate tobacco and nicotine products.

The investigation follows an assessment by the quasi-independent Reagan-Udall Foundation that the CTP had not clearly outlined the most basic elements of its regulatory programs, resulting in confusion, inefficiency, litigation, and suspicions of political interference.

Read full article
I'm already a subscriber
Author default picture


This article was written by one of TobaccoIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual nicotine markets.

Our Key Benefits

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation